RXO (NYSE: RXO) reported Q3 EPS of $0.05, $0.08 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.05 billion.

Fourth-Quarter Outlook

RXO expects fourth-quarter 2024 adjusted EBITDA to be between $40 million and $45 million. The company expects fourth-quarter 2024 Brokerage gross margin to be between 12% and 14%.

For earnings history and earnings-related data on RXO (RXO) click here.